Skip to main content

Advertisement

Table 4 Multivariate analysis of overall expenditure for diagnosis and treatment of 2356 patients with colorectal cancer

From: Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey

Characteristic Estimate (95% CI) P
Intercept 10.4 (10.2, 10.5) <0.001
Hospital type (Ref = general)
 Specialized 0.2 (0.1, 0.2) <0.001
Age at diagnosis (years) (Ref = ≥65)
 <45 0.0 (−0.1, 0.1) 0.419
 45–54 0.1 (0.0, 0.2) 0.131
 55–64 0.0 (−0.1, 0.1) 0.522
Sex (Ref = women)
 Men 0.0 (−0.1, 0.1) 0.969
Education (Ref = primary school or below)
 Junior high school 0.0 (−0.1, 0.1) 0.815
 Senior high school 0.0 (0.0, 0.1) 0.310
 Undergraduate or higher 0.1 (0, 0.2) 0.134
Occupation (Ref = self-employee or unemployee)
 Farmer 0.0 (−0.1, 0.2) 0.493
 Enterprise or company employee/worker −0.1 (−0.2, 0.0) 0.057
 Retiree 0.1 (−0.1, 0.2) 0.377
 Public sector employee 0.2 (0.1, 0.3) 0.004
 Other 0.0 (−0.3, 0.2) 0.778
Healthcare insurance type (Ref = new rural cooperative medical scheme)   
 Urban employee basic medical insurance 0.0 (−0.1, 0.1) 0.641
 Urban resident basic medical insurance 0.0 (−0.1, 0.1) 0.707
 Commercial insurance 0.0 (−0.3, 0.4) 0.792
 Self-paid 0.0 (−0.2, 0.2) 0.905
 Other 0.4 (0.1, 0.7) 0.020
Previous-year household income (CNY) (Ref = ≤20,000)
 20,000–39,999 0.1 (0.0, 0.2) 0.006
 40,000–69,999 0.1 (0.0, 0.2) 0.046
 ≥70,000 0.1 (0.0, 0.2) 0.006
Clinical stage (Ref = I)
 II 0.0 (−0.1, 0.1) 0.822
 III 0.1 (0.0, 0.2) 0.099
 IV 0.3 (0.1, 0.4) <0.001
Pathologic type (Ref = others)
 Adenocarcinoma 0.2 (0.1, 0.3) <0.001
Therapeutic regimen (Ref = surgery)
 Chemotherapy 0.2 (0.1, 0.3) <0.001
 Surgery and postoperative chemotherapy 0.2 (0.1, 0.3) <0.001
 Symptomatic treatment 0.1 (0.0, 0.2) 0.170
 Concurrent chemoradiotherapy 0.8 (0.6, 1.0) <0.001
 Radiotherapy 0.5 (0.3, 0.7) <0.001
 Neoadjuvant chemotherapy and surgery 0.2 (−0.2, 0.6) 0.251
  1. CNY Chinese Yuan, CI confidence interval